Press Information BureauHealth
India proposes swift licence suspensions for substandard drugs
India’s health ministry has proposed immediately suspending manufacturing licences for medicines that fail key prescribed standards. The move is intended to strengthen drug quality oversight, but the ministry has described it as a proposal, not a rule already in force.
This card is an AI-assisted summary of reporting published by Press Information Bureau. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.